Procaps Group, S.A Net Income 2020-2023 | PROCF
Procaps Group, S.A net income from 2020 to 2023. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Procaps Group, S.A Annual Net Income
(Millions of US $) |
| 2022 |
$43 |
| 2021 |
$-101 |
| 2020 |
$-10 |
| 2020 |
$-13 |
| 2019 |
$-17 |
| 2019 |
$-0 |
| 2018 |
$-0 |
Procaps Group, S.A Quarterly Net Income
(Millions of US $) |
| 2023-09-30 |
$8 |
| 2023-06-30 |
$27 |
| 2023-03-31 |
$7 |
| 2022-12-31 |
$10 |
| 2022-09-30 |
$23 |
| 2022-06-30 |
$-7 |
| 2022-03-31 |
$16 |
| 2021-12-31 |
$28 |
| 2021-09-30 |
$-111 |
| 2021-06-30 |
$-1 |
| 2021-03-31 |
$-17 |
| 2020-12-31 |
$-6 |
| 2020-09-30 |
$-1 |
| 2020-06-30 |
$-4 |
| 2020-03-31 |
$2 |
| 2019-12-31 |
$-2 |
| 2019-09-30 |
|
| 2019-06-30 |
|
| 2019-03-31 |
$-0 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-DRUGS |
$0.125B |
$0.410B |
|
Procaps Group is a developer of pharmaceutical and nutraceutical solutions, medicines and hospital supplies. It develops, manufactures and markets over-the-counter and prescription drugs, nutritional supplements and high-potency clinical solutions. Procaps Group, formerly known as Union Acquisition Corp. II, is based in BARRANQUILLA, Colombia.
|
